Literature DB >> 24049178

Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia.

Haider Al-Hello1, Jaume Jorba, Soile Blomqvist, Riina Raud, Olen Kew, Merja Roivainen.   

Abstract

Highly divergent vaccine-derived polioviruses (VDPVs) have been isolated from sewage in Tallinn, Estonia, since 2002. Sequence analysis of VDPVs of serotypes 2 and 3 showed that they shared common noncapsid region recombination sites, indicating origination from a single trivalent oral polio vaccine dose, estimated to have been given between 1986 and 1998. The sewage isolates closely resemble VDPVs chronically excreted by persons with common variable immunodeficiency, but no chronic excretors have yet been identified in Estonia.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24049178      PMCID： PMC3838114          DOI： 10.1128/JVI.01174-13

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Antigenic structure of picornaviruses.

Authors:  P D Minor
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.

Authors:  G D Westrop; K A Wareham; D M Evans; G Dunn; P D Minor; D I Magrath; F Taffs; S Marsden; M A Skinner; G C Schild
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.

Authors:  H Toyoda; M Kohara; Y Kataoka; T Suganuma; T Omata; N Imura; A Nomoto
Journal:  J Mol Biol       Date:  1984-04-25       Impact factor: 5.469

4.  Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children.

Authors:  Marie-Line Joffret; Sophie Jégouic; Maël Bessaud; Jean Balanant; Coralie Tran; Valerie Caro; Barbara Holmblat; Richter Razafindratsimandresy; Jean-Marc Reynes; Mala Rakoto-Andrianarivelo; Francis Delpeyroux
Journal:  J Infect Dis       Date:  2012-03-29       Impact factor: 5.226

5.  Intertypic genomic rearrangements of poliovirus strains in vaccinees.

Authors:  N Cammack; A Phillips; G Dunn; V Patel; P D Minor
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

6.  Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient.

Authors:  A Bellmunt; G May; R Zell; P Pring-Akerblom; W Verhagen; A Heim
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

7.  Identification of two determinants that attenuate vaccine-related type 2 poliovirus.

Authors:  R B Ren; E G Moss; V R Racaniello
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia.

Authors:  Soile Blomqvist; Carita Savolainen; Pia Laine; Päivi Hirttiö; Elisa Lamminsalo; Eija Penttilä; Silver Jöks; Merja Roivainen; Tapani Hovi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.

Authors:  Nino Khetsuriani; D Rebecca Prevots; Linda Quick; Melissa E Elder; Mark Pallansch; Olen Kew; Roland W Sutter
Journal:  J Infect Dis       Date:  2003-12-08       Impact factor: 5.226

10.  Poliomyelitis in the world.

Authors:  W C Cockburn; S G Drozdov
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408
View more
  10 in total

1.  Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.

Authors:  Jing Shaw; Jaume Jorba; Kun Zhao; Jane Iber; Qi Chen; Festus Adu; Adekunle Adeniji; David Bukbuk; Marycelin Baba; Elizabeth Henderson; Naomi Dybdahl-Sissoko; Sharla McDonald; William C Weldon; Nicksy Gumede; M Steven Oberste; Olen M Kew; Cara C Burns
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

Review 2.  Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.

Authors:  Radboud J Duintjer Tebbens; Marita Zimmermann; Mark A Pallansch; Kimberly M Thompson
Journal:  Food Environ Virol       Date:  2017-07-07       Impact factor: 2.778

3.  Detection of pathogenic viruses in sewage provided early warnings of hepatitis A virus and norovirus outbreaks.

Authors:  Maria Hellmér; Nicklas Paxéus; Lars Magnius; Lucica Enache; Birgitta Arnholm; Annette Johansson; Tomas Bergström; Heléne Norder
Journal:  Appl Environ Microbiol       Date:  2014-08-29       Impact factor: 4.792

Review 4.  Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.

Authors:  P L Lopalco
Journal:  Epidemiol Infect       Date:  2016-11-21       Impact factor: 4.434

5.  Molecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014.

Authors:  Klécia Marília S de Melo Cassemiro; Fernanda M Burlandy; Mikaela R F Barbosa; Qi Chen; Jaume Jorba; Elayse M Hachich; Maria I Z Sato; Cara C Burns; Edson E da Silva
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

6.  Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters.

Authors:  D A Kalkowska; M A Pallansch; K M Thompson
Journal:  Epidemiol Infect       Date:  2019-10-24       Impact factor: 2.451

7.  Case of Poliomyelitis Caused by Significantly Diverged Derivative of the Poliovirus Type 3 Vaccine Sabin Strain Circulating in the Orphanage.

Authors:  Ekaterina A Korotkova; Maria A Prostova; Anatoly P Gmyl; Liubov I Kozlovskaya; Tatiana P Eremeeva; Olga Y Baikova; Alexandr Y Krasota; Nadezhda S Morozova; Olga E Ivanova
Journal:  Viruses       Date:  2020-09-01       Impact factor: 5.048

8.  Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2015-09-17       Impact factor: 3.090

9.  The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda.

Authors:  Mary Bridget Nanteza; Barnabas Bakamutumaho; Annet Kisakye; Prossy Namuwulya; Henry Bukenya; Edson Katushabe; Josephine Bwogi; Charles Rutebarika Byabamazima; Raffaella Williams; Nicksy Gumede
Journal:  Virol J       Date:  2018-04-27       Impact factor: 4.099

10.  Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013.

Authors:  Ousmane M Diop; Cara C Burns; Steven G Wassilak; Olen M Kew
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-03-21       Impact factor: 17.586
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.